CD274 and neoplasm: This strategy of tumor stratification can explain why some patients with tumors expressing immunosuppressive molecules such as PD-L1 and/or indoleamine 2,3-dioxygenase (IDO) are more likely to respond to ICIs compared to tumors lacking these molecules.